We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.13B
AUM Growth
+$319M
Cap. Flow
+$340M
Cap. Flow %
30.14%
Top 10 Hldgs %
55.39%
Holding
5,820
New
1,131
Increased
1,662
Reduced
1,677
Closed
1,186

Sector Composition

Rank Sector Weight
1 Financials 2.49%
2 Industrials 2.24%
3 Healthcare 2.07%
4 Consumer Discretionary 2.05%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENOV icon
551
Enovis
ENOV
$1.68B
$146K 0.01%
1,832
+154
+9% +$13K
TDAY
552
USA Today Co
TDAY
$1.27B
$146K 0.01%
8,139
+6,293
+341% +$134K
RVTY icon
553
Revvity
RVTY
$12.6B
$146K 0.01%
2,779
+1,089
+64% +$56.8K
USB icon
554
US Bancorp
USB
$98.2B
$146K 0.01%
3,375
+2,103
+165% +$91.9K
UN
555
DELISTED
Unilever NV New York Registry Shares
UN
$146K 0.01%
3,487
+3,032
+666% +$131K
ABM icon
556
ABM Industries
ABM
$2.81B
$145K 0.01%
4,404
-1,631
-27% -$52.9K
HLF icon
557
Herbalife
HLF
$1.29B
$145K 0.01%
5,272
+2,380
+82% +$57.6K
NHTC icon
558
Natural Health Trends
NHTC
$14.7M
$145K 0.01%
3,516
+2,440
+227% +$72.3K
RNG icon
559
RingCentral
RNG
$4.66B
$145K 0.01%
+7,864
New +$137K
TUR icon
560
iShares MSCI Turkey ETF
TUR
$209M
$145K 0.01%
3,206
-147
-4% -$6.91K
CAT icon
561
Caterpillar
CAT
$375B
$144K 0.01%
+1,700
New +$146K
HEI icon
562
HEICO Corp
HEI
$49.8B
$144K 0.01%
6,045
+1,018
+20% +$24.4K
UTHR icon
563
United Therapeutics
UTHR
$25.8B
$144K 0.01%
825
-518
-39% -$93.2K
AXTA icon
564
Axalta
AXTA
$7.66B
$143K 0.01%
4,315
+4,215
+4,215% +$139K
FCNCA icon
565
First Citizens BancShares
FCNCA
$24.9B
$143K 0.01%
545
-15
-3% -$3.73K
QLTA icon
566
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.24B
$143K 0.01%
+2,828
New +$146K
UNFI icon
567
United Natural Foods
UNFI
$3.08B
$143K 0.01%
2,250
+769
+52% +$52.1K
SUSQ
568
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
$143K 0.01%
10,104
-8,065
-44% -$112K
AWI icon
569
Armstrong World Industries
AWI
$7.38B
$142K 0.01%
2,678
+2,097
+361% +$117K
CL icon
570
Colgate-Palmolive
CL
$73.1B
$142K 0.01%
2,169
+2,069
+2,069% +$140K
IMAX icon
571
IMAX
IMAX
$2.62B
$142K 0.01%
3,516
+706
+25% +$27.4K
TIMB icon
572
TIM SA
TIMB
$9.16B
$142K 0.01%
8,686
+886
+11% +$14.1K
EFII
573
DELISTED
Electronics for Imaging
EFII
$141K 0.01%
3,244
+1,158
+56% +$49.9K
EPD icon
574
Enterprise Products Partners
EPD
$82.3B
$140K 0.01%
4,671
-3,731
-44% -$122K
CSGS
575
DELISTED
CSG Systems International
CSGS
$139K 0.01%
4,393
+2,664
+154% +$82.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2015 Portfolio in Review

As of Q2 2015, Tower Research Capital (TRC) held 5,820 positions worth $1.13B, up 39% from $809M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC) deployed $340M of net new capital in Q2 2015, opening 1,131 new positions and adding to 1,662 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.

By sector, the portfolio is most concentrated in Financials at 2.5% of assets, down from 4.6% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $42.4M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2015 buy was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $337M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2015 reduction was Invesco QQQ Trust, cutting an estimated $42.4M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q2 2015, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.13B portfolio in Q2 2015.
  • Tower Research Capital (TRC) opened 1,131 new positions and closed 1,186 in Q2 2015.
  • Tower Research Capital (TRC)'s portfolio value rose 39% quarter-over-quarter to $1.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.